JP6453781B2 - ヒトｐｉ３ｋｃａ（ｐｉｋ３ｃａ）遺伝子変異検出のための方法及び組成物 - Google Patents

ヒトｐｉ３ｋｃａ（ｐｉｋ３ｃａ）遺伝子変異検出のための方法及び組成物 Download PDF

Info

Publication number
JP6453781B2
JP6453781B2 JP2015562104A JP2015562104A JP6453781B2 JP 6453781 B2 JP6453781 B2 JP 6453781B2 JP 2015562104 A JP2015562104 A JP 2015562104A JP 2015562104 A JP2015562104 A JP 2015562104A JP 6453781 B2 JP6453781 B2 JP 6453781B2
Authority
JP
Japan
Prior art keywords
oligonucleotide
seq
mutation
nucleotide
allele
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015562104A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016510982A5 (https=
JP2016510982A (ja
Inventor
ツァン アリソン
ツァン アリソン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2016510982A publication Critical patent/JP2016510982A/ja
Publication of JP2016510982A5 publication Critical patent/JP2016510982A5/ja
Application granted granted Critical
Publication of JP6453781B2 publication Critical patent/JP6453781B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2015562104A 2013-03-13 2014-03-12 ヒトｐｉ３ｋｃａ（ｐｉｋ３ｃａ）遺伝子変異検出のための方法及び組成物 Active JP6453781B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361780017P 2013-03-13 2013-03-13
US61/780,017 2013-03-13
PCT/EP2014/054766 WO2014140061A2 (en) 2013-03-13 2014-03-12 Methods and compositions for detecting mutations in the human pi3kca (pik3ca) gene

Publications (3)

Publication Number Publication Date
JP2016510982A JP2016510982A (ja) 2016-04-14
JP2016510982A5 JP2016510982A5 (https=) 2018-09-06
JP6453781B2 true JP6453781B2 (ja) 2019-01-16

Family

ID=50277211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015562104A Active JP6453781B2 (ja) 2013-03-13 2014-03-12 ヒトｐｉ３ｋｃａ（ｐｉｋ３ｃａ）遺伝子変異検出のための方法及び組成物

Country Status (7)

Country Link
US (2) US20140272961A1 (https=)
EP (1) EP2971075B1 (https=)
JP (1) JP6453781B2 (https=)
CN (2) CN108130373A (https=)
CA (1) CA2899712C (https=)
ES (1) ES2691306T3 (https=)
WO (1) WO2014140061A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201206486D0 (en) * 2012-04-12 2012-05-30 Sequessome Technology Holdings Ltd Vesicular formulations and uses thereof
WO2018094569A1 (zh) * 2016-11-22 2018-05-31 深圳华大基因研究院 多肽及其应用
CN109913481B (zh) * 2019-04-24 2020-04-03 无锡市第五人民医院 PIK3CA基因g.179224821G＞A突变及其在乳腺癌辅助诊断中的应用
KR102813811B1 (ko) * 2020-03-27 2025-05-30 주식회사 젠큐릭스 Pik3ca 돌연변이 검출용 조성물 및 이를 포함하는 키트
CN111363827A (zh) * 2020-04-30 2020-07-03 北京和合医学诊断技术股份有限公司 用于检测pik3ca基因突变的引物组及其应用方法
CN114410790B (zh) * 2022-01-27 2024-04-12 湖南大学 一种用于检测ctDNA的生物传感检测系统及其检测方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3296407T1 (sl) * 2004-03-02 2019-09-30 The Johns Hopkins University Mutacije gena PIK3CA pri rakih pri ljudeh
GB2453173A (en) * 2007-09-28 2009-04-01 Dxs Ltd Polynucleotide primers
ES2527653T3 (es) * 2008-10-20 2015-01-28 F. Hoffmann-La Roche Ag Amplificación específica de alelo usando un cebador con un nucleótido modificado
US20100286143A1 (en) * 2009-04-24 2010-11-11 Dora Dias-Santagata Methods and materials for genetic analysis of tumors
US9238832B2 (en) * 2009-12-11 2016-01-19 Roche Molecular Systems, Inc. Allele-specific amplification of nucleic acids
CA2786696C (en) * 2010-01-12 2021-05-25 Jill Detmer Oligonucleotides and methods for detecting pik3ca mutations
CN102234685B (zh) * 2010-04-23 2014-08-27 益善生物技术股份有限公司 一种pik3ca基因突变检测液相芯片
KR101825121B1 (ko) * 2010-08-13 2018-02-06 주식회사 파나진 Ｐｎａ 기반의 실시간 ｐｃｒ 클램핑을 이용한 ｐｉｋ3ｃａ 돌연변이 검출 방법 및 키트
JP6050820B2 (ja) * 2011-09-23 2016-12-21 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 改良された対立遺伝子特異的ｐｃｒのためのｇ−クランプの使用

Also Published As

Publication number Publication date
CA2899712A1 (en) 2014-09-18
CN108130373A (zh) 2018-06-08
WO2014140061A2 (en) 2014-09-18
CA2899712C (en) 2021-01-05
US20160160297A1 (en) 2016-06-09
JP2016510982A (ja) 2016-04-14
EP2971075A2 (en) 2016-01-20
CN105229171A (zh) 2016-01-06
EP2971075B1 (en) 2018-08-15
ES2691306T3 (es) 2018-11-26
WO2014140061A3 (en) 2014-10-30
US20140272961A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
CA2957396C (en) Method of determining pik3ca mutational status in a sample
JP5750710B2 (ja) 癌マーカー、それを用いた癌の評価方法および評価試薬
JP6453781B2 (ja) ヒトｐｉ３ｋｃａ（ｐｉｋ３ｃａ）遺伝子変異検出のための方法及び組成物
CN110964814B (zh) 用于核酸序列变异检测的引物、组合物及方法
JP6619332B2 (ja) ヒトｅｚｈ２遺伝子中の変異を検出するための方法及び組成物
JP6438119B2 (ja) ホットスポット変異の迅速かつ高感度の検出のための方法
JP2014500028A (ja) ヒト上皮成長因子受容体遺伝子内の突然変異を検出するための方法及び組成物
EP3458614A1 (en) Methods of detecting a mutated gene by multiplex digital pcr
JP2016510982A5 (https=)
US12391985B2 (en) Method of determining PIK3CA mutational status in a sample
JP6153758B2 (ja) 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用キット
JP6243342B2 (ja) 上皮増殖因子受容体キナーゼ・ドメイン内の新規な複合突然変異
CN110964833B (zh) 一种一管检测血浆游离dna中kras和braf基因突变的试剂盒
JP6205216B2 (ja) 変異検出用プローブ、変異検出方法、薬効判定方法及び変異検出用キット
JPWO2016103727A1 (ja) 特異的核酸配列の増幅促進方法
JP2016500253A (ja) 上皮成長因子受容体キナーゼドメインにおける新規変異
HK1241934A1 (en) Method of determining pik3ca mutational status in a sample

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170224

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180130

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180427

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20180730

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20181113

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181213

R150 Certificate of patent or registration of utility model

Ref document number: 6453781

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250